• Our Company
  • Leadership
    • Executive Officers
    • Board of Directors
    • Scientific Advisory Board
  • Philanthropy
    • Hamilton Naki - MESAB - Unither Scholarship
  • Strategic Objectives
• Products
• Patient Support
• Pipeline
  • UT-15C Treprostinil Diethanolamine Sustained Release Tablets (Oral Treprostinil)
  • ch14.18 for Neuroblastoma
  • Remodulin® via Implantable Pump
  • Beraprost-MR for PAH
  • 8H9 MAb for Metastatic Brain Cancer
  • IW001 for IPF and PGD
  • Glycobiology Antiviral Agents
  • PLX Cells
  • Pulmonary Tissue Replacement and Remodeling
• Investor Relations
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Investor FAQs
  • Contact Us
• Careers
  • Our Employees
  • Our Workforce
  • Professional Development
  • Benefits
  • Diversity
  • Job Openings
  • Equal Opportunity Employer
• Contact

RSS Feed